Suwarti1 , Sabighoh Zanjabila1 , Yunita Windi Anggraini1 , Robert Sinto2,3,4 , Yanie Tayipto1,5 , J. Kevin Baird1,6 , Anuraj H. Shankar 1,6 , Le Van Tan7 , Tan Chee Wah8 , Susanna Dunachie5 , Barbara Kronsteiner-Dobramysl5 , Martha Zewdie 5 , Juthathip Mongkolsapaya 6,9 , Wanwisa Dejnirattisai10 , Erni J. Nelwan2,3 , and Raph L. Hamers1,6 for the SEACOVARIANTS Consortium
Abstract
SEACOVARIANTS is a Wellcome-funded multidisciplinary research platform to strengthen regional scientific capacity to enable the locally-led research response to the COVID-19 pandemic and future outbreaks across Southeast Asia.
Key Achievements:
- SEACOVARIANTS has strengthened local capacities and collaborative networks with scientists and stakeholders at OUCRU Indonesia, including policymakers
- A sustainable platform for surveillance, research and policy engagement, thus enabling effective localized responses and outbreak preparedness
- Target areas expanding from SARS-CoV-2 to Mpox and other emerging respiratory viruses
1Oxford University Clinical Research Unit Indonesia, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
2 Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
3 Division of Tropical and Infectious Diseases, Department of Internal Medicine, Cipto Mangunkusumo National Hospital, Jakarta, Indonesia
4 St Carolus Hospital, Jakarta Indonesia
5 Centre for Tropical Medicine and Global Health, University of Oxford, UK
6 Nuffield Department of Medicine, University of Oxford, UK
7 Oxford University Clinical Research Unit Vietnam
8 Duke, School of Medicine, NUS, Singapore
9 MORU-Tropical Health Network, Bangkok, Thailand
10 Mahidol University, Bangkok, Thailand